SUBLINGUAL SUFENTINAL APPROVED BY FDA
Potential for abuse addiction is phenomenally high.
DSUVIA is indicated for the management of acute pain in adults that is severe enough to require an opioid analgesic in certified medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments.
DSUVIA is a 30 microgram (mcg) sufentanil tablet in a single-dose, pre-filled applicator for under the tongue (sublingual) administration by a healthcare professional only in certified medically supervised settings.
https://www.streetinsider.com/Corporate+News/AcelRx+%28ACRX%29+Confirms+FDA+approval+of+DSUVIA/14779423.html